InvestorsHub Logo
Followers 155
Posts 2659
Boards Moderated 0
Alias Born 01/29/2004

Re: Fireman02360 post# 117891

Wednesday, 08/30/2017 3:36:29 PM

Wednesday, August 30, 2017 3:36:29 PM

Post# of 467092
Yes, Seizure Control Alone Will Prompt FDA Approval

I'm no expert, by any means, on Rett syndrome. I've pondered the outcomes of a failure of the Rett syndrome trial (presuming, however, that the company knows from the start, from animal data, that it will be a big success).

I questioned the possibility that Anavex 2-73 might be able to fully restore or create normal nerve and body functions, as many of these not functioning in Rett syndrome don't appear to be open to sigma-1 receptor agonist treatment.

We all hope that's not so, that Anavex 2-73, by whatever means, might bring full health to the children with the disease.

But, I, too, think that if suppression or termination of epilepsy in Rett patients were all that the up-coming trial might demonstrate, FDA approval would be forthcoming. Safe suppression of this set of symptoms would be a marked quality of life improvement, worthy of Anavex 2-73 usage.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News